daftar pustaka - institutional repository undip (undip...
TRANSCRIPT
38
DAFTAR PUSTAKA
1. Lestari Weny, Wardhani Yurika Fauzia. Stigma dan Penanganan Penderita
Gangguan Jiwa Berat yang Dipasung. 2014;157–66.
2. Jarut Yulia Maria, Fatimawali, Wiyono Weny. Tinjauan Penggunaan
Antipsikotik Pada Pengobatan Skizofrenia Di Rumah Sakit Prof . Dr . V . L
Ratumbuysang Manado Periode Januari 2013-Maret 2013. Jurnal Ilmiah
Farmasi. 2013;2(03):54–7.
3. Sadock Benjamin, Sadock Virgnia. Kaplan & Sadock’s Concise Textbook
of Clinical Psychiatry. 2nd ed. Jakarta: EGC; 2013.
4. Johnson D a W. Historical perspective on antipsychotic long-acting
injections. British Journal of Psychiatry. 2009;195(SUPPL. 52):7–13.
5. Kane John M, Garcia-Ribera Carlos. Clinical guideline recommendations for
antipsychotic long-acting injections. British Journal of Psychiatry.
2009;195(SUPPL. 52):63–8.
6. Wistedt Borje. How does the psychiatric patient feel about depot treatment,
compulsion or help. Nordic Journal of Psychiatry [Internet]. Taylor &
Francis; 1995 Jan 1;49(sup35):41–6. Available from:
http://www.tandfonline.com/doi/abs/10.3109/08039489509099719
7. Marwick Katie FM, Taylor Mark, Walker Simon W. Antipsychotics and
abnormal liver function tests: systematic review. Clinical
neuropharmacology [Internet]. 2012;35(5):244–53. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22986798
8. Bošković Marija, Grabnar Iztok, Terzič Tea, Kores Plesničar Blanka, Vovk
Tomaz. Oxidative stress in schizophrenia patients treated with long-acting
haloperidol decanoate. Psychiatry Research. 2013;210(3):761–8.
9. Sunarno. The Gluttathion Role As Antioxidant in Inhibition of Neurode
generative Disease and Brain Aging. Semarang; 2009;1(2):185–210.
10. Bo M, Vovk T, Kores B, Grabnar I. Oxidative Stress in Schizophrenia.
2011;301–12.
11. Murray RK, Granner DK. Harper’s Illustrated Biochemistry. 27 th. Jakarta:
EGC; 2009.
39
12. Yu L, Zhao M, Yang B, Zhao Q, Jiang Y. Phenolics from hull of Garcinia
mangostana fruit and their antioxidant activities. Food Chemistry.
2007;104(1):176–81.
13. Mansour NAA, Aulani’am, Kusnadi J. Garciniamangostana Linn . Pericarp
Extract Reduced Malondialdehyde ( MDA ) Level in Cigarette Smoke
Exposed Rats. 2013;2(9):1–5.
14. Tjahjani S, Widowati W, Khiong K, Suhendra A, Tjokropranoto R.
Antioxidant Properties of Garcinia Mangostana L (Mangosteen) Rind.
Procedia Chemistry [Internet]. Elsevier Ltd.; 2014 [cited 2015 Dec
23];13(2009):198–203. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S1876619614002162
15. Gumulec J, Raudenska M, Hlavna M, Stracina T, Sztalmachova M,
Tanhauserova V, et al. Determination of oxidative stress and activities of
antioxidant enzymes in guinea pigs treated with haloperidol. Experimental
and therapeutic medicine [Internet]. 2013;5(2):479–84. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3570091&tool=
pmcentrez&rendertype=abstract
16. Meltzer H. Antipsychotic Agents & Lithium. In: Katzung BG, editor. Basic
and clinical Pharmacology. 12 th. San Francisco: McGraw-Hill; 2012. p.
501–20.
17. Brissos S, Veguilla MR, Taylor D, Balanzá-martinez V. Therapeutic
Advances in Psychopharmacology The role of long-acting injectable
antipsychotics in schizophrenia : a critical appraisal. 2014;
18. Olivares JM, Pinal B, Cinos C. Comparison of long-acting antipsychotic
injection and oral antipsychotics in schizophrenia. Neuropsychiatry
[Internet]. 2011;1(3):275–89. Available from:
http://www.embase.com/search/results?subaction=viewrecord&from=expor
t&id=L364450714\nhttp://dx.doi.org/10.2217/npy.11.24
19. William Z. Potter LEH. Drugs that act in the central nervous system. In:
Bertram G. Katzung, editor. Basic & Clinical Pharmacology. 12 th. United
States of America: The McGraw-Hill Companies; 2012.
40
20. Henryk-gutt R. The Effect of Flufenazin dekanoat ( Modecater ) on Hepatic
Microsomal Enzyme Activity in Man. Br J clin Pharmac. 1974;1:1973–4.
21. Jung H-A, Su B-N, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant
Xanthones from the Pericarp of Garcinia mangostana (Mangosteen).
Agriculture and Food Chemistry. 2006;54:2077–82.
22. Weecharangsan W, Opanasopit P, Sukma M, Ngawhirunpat T, Sotanaphun
U, Siripong P. Antioxidative and neuroprotective activities of extracts from
the fruit hull of mangosteen (Garcinia mangostana Linn.). Medical Principles
and Practice. 2006;15(4):281–7.
23. Azzahra H, Pujiastuti P. Potensi Ekstrak Kulit Buah Manggis ( Garcinia
mangostana L .) Buatan Pabrik Terhadap Peningkatan Aktivitas
Mikrobisidal Sel Neutrofil yang Dipapar Streptococcus mutans ( The
Potency of Manufactured Mangosteen Peel Extract ( Garcin- ia mangostana
L .) Towa. 2014;2(1):161–6.
24. Jujun P, Pootakham K, Pongpaibul Y, Duangrat C, Tharavichitkul P. Acute
and repeated dose 28-day oral toxicity study of Garcinia mangostana Linn
rind extract. J Nat Sci. 2008;7:206–199.
25. Chen C-H. Activation and Detoxification Enzymes. New York: Springer;
2012.
26. Ho E, Karimi Galougahi K, Liu C-C, Bhindi R, Figtree GA. Biological
markers of oxidative stress: Applications to cardiovascular research and
practice. Redox Biology [Internet]. Elsevier; 2013 [cited 2016 Jan
12];1(1):483–91. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S221323171300058X
27. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress
and antioxidant defense. The World Allergy Organization journal [Internet].
2012;5(1):9–19. Available from: http://www.waojournal.org/content/5/1/9
28. Jarut YM, Fatimawali, Wiyono WI. Tinjauan Penggunaan Antipsikotik Pada
Pengobatan Skizofrenia Di Rumah Sakit Prof . Dr . V . L . Jurnal Ilmiah
Farmasi. 2013;2(03):54–7.
29. Weydert CJ, Cullen JJ. Measurement of Superoxide Dismutase, Catalase,
41
and Glutathione Peroxidase in Cultured Cells and Tissue. Nat Protoc.
2010;5(1):51–66.
30. N.a. General Guidelines for Methodologies on Research and Evaluation of
Traditional Medicine World Health Organization. World Health
Organization (WHO) [Internet]. 2000;1:1–71. Available from:
http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:General+
Guidelines+for+Methodologies+on+Research+and+Evaluation+of+Traditi
onal+Medicine+World+Health+Organization#0
31. Kuribara H, Tadokoro S. Study of Accummulation of Fluphenazine
Enanthate and Flufenazin dekanoat, Long Acting Neuropletic Drugs, After
Repeated Administrarions By Means of Their Inhibitory Effects on the
Discriminated Avoidance Response in Rats. The Journal of Toxicological
Sciences. 1978;4:87–9.
32. Iwase T, Tajima A, Sugimoto S, Okuda K, Hironaka I, Kamata Y, et al. A
simple assay for measuring catalase activity: a visual approach. Scientific
reports [Internet]. 2013;3(January 2016):3081. Available from:
http://www.nature.com/srep/2013/131030/srep03081/full/srep03081.html
33. Cadet JL, Perumal AS. Chronic treatment with prolixin causes oxidative
stress in rat brain. Biological Psychiatry. 1990;28:738–40.
34. Henryk-gutt R. The Effect of Fluphanzine decanoat (Modecater) on Hepatic
Microsomal Enzyme Activity in Man. Br J clin Pharmac. 1974;1:277–8.
35. Cichoz-Lach H, Michalak A. Oxidative stress as a crucial factor in liver
diseases. World Journal of Gastroenterology. 2014;20(25):8082–91.
36. Pedraza-Chaverri J, C??rdenas-Rodr??guez N, Orozco-Ibarra M, P??rez-
Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food
and Chemical Toxicology [Internet]. Elsevier Ltd; 2008;46(10):3227–39.
Available from: http://dx.doi.org/10.1016/j.fct.2008.07.024
37. Azzahra H, Pujiastuti P, Gigi FK, Jember U, Periodonsia B, Gigi FK, et al.
Potensi Ekstrak Kulit Buah Manggis ( Garcinia mangostana L .) Buatan
Pabrik Terhadap Peningkatan Aktivitas Mikrobisidal Sel Neutrofil yang
Dipapar Streptococcus mutans ( The Potency of Manufactured Mangosteen
42
Peel Extract ( Garcin- ia mangostana L .) Towa. 2014;2(1):161–6.
38. Veeraraghavan VP, Mohan SK, Jainu M, Gopan CS. Ameliorating effects of
Garcinia mangostana Linn pericarp extract on hepatic antioxidants in Diethyl
nitrosamine ( DEN ) induced Hepatocellular Carcinoma ( HCC ).
2015;49(4).
39. Pal PB, Sinha K, Sil PC. Mangiferin, a Natural Xanthone, Protects Murine
Liver in Pb(II) Induced Hepatic Damage and Cell Death via MAP Kinase,
NF-??B and Mitochondria Dependent Pathways. PLoS ONE. 2013;8(2):1–
17.
40. Dash DK, Yeligar VC, Nayak SS, Ghosh T, Rajalingam R, Sengupta P, et al.
Evaluation of hepatoprotective and antioxidant activity of {Ichnocarpus}
frutescens ({Linn}.) {R}.{Br}. on paracetamol-induced hepatotoxicity in
rats. Tropical Journal of Pharmaceutical Research [Internet]. 2007;6(3):755–
65. Available from: http://www.ajol.info/index.php/tjpr/article/view/14656
41. Dewi MR. Pengaruh Hepatoprotektor Madu Terhadap Kerusakan Histologis
Sel Hepar Mencit ( Mus musculus ) Yang Diberi Perlakuan Natrium. 2010;
42. Oyejide OJOO, Olushola L. Hepatoprotective and antioxidant properties of
extract of Carmellia sinensis (Black tea) in rats. Journal of Biotechnology.
2005;4(December):1432–8.
43. Lohr JB, Kuczenski R, Niculescu AB. Oxidative mechanisms and tardive
dyskinesia. CNS Drugs. 2003;17(1):47–62.
43
Lampiran 1 Penghitungan dosis flufenazin dekanoat
Setiap 1 ampul berisi 25 mg Flufenazin dekanoat, dilarutkan menggunakan
sesame oil 10 ml yang telah disterilkan. Penghitungan dosis menggunakan
rumus:
𝑑𝑜𝑠𝑖𝑠 𝑦𝑎𝑛𝑔 𝑑𝑖𝑖𝑛𝑔𝑖𝑛𝑘𝑎𝑛 (𝑚𝑔)
𝑑𝑜𝑠𝑖𝑠 1 𝑎𝑚𝑝𝑢𝑙 (𝑚𝑔) 𝑋 10 𝑚𝑙 𝑋 𝑏𝑒𝑟𝑎𝑡 𝑡𝑖𝑘𝑢𝑠 (𝑘𝑔)
Penghitungan dosis Flufenazin dekanoat 2 mg/kgBB
2
25𝑋 10 𝑋 … . (𝑘𝑔)
Berat tikus (kg) Dosis 2 mg/kgBB
0,19 0,152
0,20 0,16
0,21 0,168
0,22 0,176
0,23 0,184
0,24 0,192
0,25 0,2
0,26 0,208
0,27 0,216
0,28 0,224
0,29 0,232
0,30 0,240
44
Lampiran 2 Penghitungan dosis ekstrak kulit manggis
Setiap 1 kaplet berisi 500 mg ekstrak kulit manggis, dilarutkan menggunakan
etanol 1 %.
Dosis yang digunakan adalah 600 mg/kgBB.13
Berat badan tikus ± 200 mg = 0,2 kg
Dosis ekstrak kulit manggis untuk tikus adalah adalah
𝐷𝑜𝑠𝑖𝑠 𝑒𝑘𝑠𝑡𝑟𝑎𝑘 𝑘𝑢𝑙𝑖𝑡 𝑚𝑎𝑛𝑔𝑔𝑖𝑠 (𝑚𝑔
𝑘𝑔𝐵𝐵) × 𝑏𝑒𝑟𝑎𝑡 𝑏𝑎𝑑𝑎𝑛 𝑡𝑖𝑘𝑢𝑠 (𝑘𝑔)
= 600𝑚𝑔
𝑘𝑔𝐵𝐵× 0,2 𝑘𝑔
= 120 𝑚𝑔
Dilarutkan dengan 30 ml etanol 1% disesuaikan dengan kapasitas minum tikus.
45
Lampiran 3 Ethical clearance
46
Lampiran 4 Surat Ijin Penelitian
47
Lampiran 5 Analisis data
Descriptives
kelompok Statistic Std. Error
katalase
k0
Mean 2,5500 ,33912
95% Confidence Interval for Mean Lower Bound 1,6085
Upper Bound 3,4915
5% Trimmed Mean 2,5556
Median 2,5000
Variance ,575
Std. Deviation ,75829
Minimum 1,50
Maximum 3,50
Range 2,00
Interquartile Range 1,38
Skewness -,226 ,913
Kurtosis -,139 2,000
p1
Mean 5,8200 ,76560
95% Confidence Interval for Mean Lower Bound 3,6943
Upper Bound 7,9457
5% Trimmed Mean 5,8222
Median 5,2500
Variance 2,931
Std. Deviation 1,71194
Minimum 3,60
Maximum 8,00
Range 4,40
Interquartile Range 3,08
Skewness ,057 ,913
Kurtosis -,865 2,000
p2
Mean 8,3000 1,54394
95% Confidence Interval for Mean Lower Bound 4,0133
Upper Bound 12,5867
5% Trimmed Mean 8,2083
Median 8,0000
Variance 11,919
48
Std. Deviation 3,45235
Minimum 5,00
Maximum 13,25
Range 8,25
Interquartile Range 6,50
Skewness ,626 ,913
Kurtosis -,839 2,000
k1
Mean 10,1700 ,89521
95% Confidence Interval for Mean Lower Bound 7,6845
Upper Bound 12,6555
5% Trimmed Mean 10,2583
Median 10,6000
Variance 4,007
Std. Deviation 2,00175
Minimum 6,75
Maximum 12,00
Range 5,25
Interquartile Range 2,88
Skewness -1,724 ,913
Kurtosis 3,564 2,000
Tests of Normality
kelompok Kolmogorov-Smirnova Shapiro-Wilk
Statistic df Sig. Statistic df Sig.
katalase
k0 ,146 5 ,200* ,992 5 ,985
p1 ,230 5 ,200* ,955 5 ,776
p2 ,212 5 ,200* ,922 5 ,543
k1 ,365 5 ,028 ,813 5 ,103
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
Test of Homogeneity of Variances
katalase
49
Levene Statistic df1 df2 Sig.
2,703 3 16 ,080
ANOVA
katalase
Sum of Squares df Mean Square F Sig.
Between Groups 162,987 3 54,329 11,184 ,000
Within Groups 77,726 16 4,858
Total 240,713 19
Multiple Comparisons
Dependent Variable: katalase
Bonferroni
(I) kelompok (J) kelompok Mean
Difference (I-J)
Std. Error Sig. 95% Confidence Interval
Lower Bound Upper Bound
k0
p1 -3,27000 1,39397 ,193 -7,4635 ,9235
p2 -5,75000* 1,39397 ,005 -9,9435 -1,5565
k1 -7,62000* 1,39397 ,000 -11,8135 -3,4265
p1
k0 3,27000 1,39397 ,193 -,9235 7,4635
p2 -2,48000 1,39397 ,565 -6,6735 1,7135
k1 -4,35000* 1,39397 ,040 -8,5435 -,1565
p2
k0 5,75000* 1,39397 ,005 1,5565 9,9435
p1 2,48000 1,39397 ,565 -1,7135 6,6735
k1 -1,87000 1,39397 1,000 -6,0635 2,3235
k1
k0 7,62000* 1,39397 ,000 3,4265 11,8135
p1 4,35000* 1,39397 ,040 ,1565 8,5435
p2 1,87000 1,39397 1,000 -2,3235 6,0635
*. The mean difference is significant at the 0.05 level.
50
Lampiran 6 Dokumentasi
51
52
53
54
55
Lampiran 7 Biodata mahasiswa
Identitas
Nama : Miranti Anggun Sari
NIM : 22010112130164
Tempat/tanggal lahir : Semarang, 25 Agustus 1994
Jenis Kelamin : Perempuan
Nomor HP : 089679094604
e-mail : [email protected]
Riwayat Pendidikan Formal
1. SD : SD Hj Isriati Baiturrahman Semarang Lulus tahun: 2006
2. SMP : SMP N 8 Semarang Lulus tahun: 2009
3. SMA : SMA N 1 Semarang Lulus tahun: 2012
4. FK UNDIP : Masuk tahun : 2012